» Articles » PMID: 27239268

Enteropathogenic E. Coli: Breaking the Intestinal Tight Junction Barrier

Overview
Journal F1000Res
Date 2016 Jun 9
PMID 27239268
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Enteropathogenic E. coli (EPEC) causes acute intestinal infections in infants in the developing world. Infection typically spreads through contaminated food and water and leads to severe, watery diarrhea. EPEC attaches to the intestinal epithelial cells and directly injects virulence factors which modulate multiple signaling pathways leading to host cell dysfunction. However, the molecular mechanisms that regulate the onset of diarrhea are poorly defined. A major target of EPEC is the host cell tight junction complex which acts as a barrier and regulates the passage of water and solutes through the paracellular space. In this review, we focus on the EPEC effectors that target the epithelial barrier, alter its functions and contribute to leakage through the tight junctions.

Citing Articles

Enteropathogenic E. coli effector Map interacts with Rab13 and regulates the depletion of the tight junction proteins occludin and claudins via cathepsin B-mediated mechanisms.

Mandal A, Walling P, Qureshi S, Kansal K, Aijaz S Biol Open. 2025; 14(2).

PMID: 39912222 PMC: 11892358. DOI: 10.1242/bio.061794.


The C-terminal proline-rich repeats of Enteropathogenic E. coli effector EspF are sufficient for the depletion of tight junction membrane proteins and interactions with early and recycling endosomes.

Ansari I, Mandal A, Kansal K, Walling P, Khan S, Aijaz S Gut Pathog. 2024; 16(1):36.

PMID: 38972985 PMC: 11229284. DOI: 10.1186/s13099-024-00626-8.


Cleavage of cell junction proteins as a host invasion strategy in leptospirosis.

Kumari P, Yadav S, Sarkar S, Satheeshkumar P Appl Microbiol Biotechnol. 2024; 108(1):119.

PMID: 38204132 PMC: 10781872. DOI: 10.1007/s00253-023-12945-y.


Pathophysiology of Enteropathogenic -induced Diarrhea.

Kaur P, Dudeja P Newborn (Clarksville). 2023; 2(1):102-113.

PMID: 37388762 PMC: 10308259. DOI: 10.5005/jp-journals-11002-0056.


Intestinal barrier functions in hematologic and oncologic diseases.

Haroun E, Ashok Kumar P, Saba L, Kassab J, Ghimire K, Dutta D J Transl Med. 2023; 21(1):233.

PMID: 37004099 PMC: 10064590. DOI: 10.1186/s12967-023-04091-w.


References
1.
Wong A, Pearson J, Bright M, Munera D, Robinson K, Lee S . Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol. 2011; 80(6):1420-38. DOI: 10.1111/j.1365-2958.2011.07661.x. View

2.
Hodges K, Alto N, Ramaswamy K, Dudeja P, Hecht G . The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity. Cell Microbiol. 2008; 10(8):1735-45. PMC: 2614392. DOI: 10.1111/j.1462-5822.2008.01163.x. View

3.
Dean P, Kenny B . Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol Microbiol. 2004; 54(3):665-75. DOI: 10.1111/j.1365-2958.2004.04308.x. View

4.
Ochoa T, Contreras C . Enteropathogenic escherichia coli infection in children. Curr Opin Infect Dis. 2011; 24(5):478-83. PMC: 3277943. DOI: 10.1097/QCO.0b013e32834a8b8b. View

5.
Aijaz S, Balda M, Matter K . Tight junctions: molecular architecture and function. Int Rev Cytol. 2006; 248:261-98. DOI: 10.1016/S0074-7696(06)48005-0. View